Social isolation tied to wide variety of dementia risk factors
Feb 02, 2023
Social isolation may be a modifiable risk factor for preventing Alzheimer’s disease-related dementias, authors say.
Psychological interventions may reduce depression in dementia patients
May 04, 2022
Treatments based on cognitive behavioral therapies may reduce depressive symptoms, but evidence is lacking for their effect on anxiety.
FDA panel recommends approval of Johnson & Johnson booster shot
Oct 15, 2021
The booster shot is recommended for anyone 18 years and older, to be given at least two months after the first dose.
Exercise, pollution may have interactive effect on brain volumes
Dec 09, 2021
Exposure to air pollution may counter the beneficial effects of physical activity on structural brain volumes.
Antidepressant combos compared to monotherapy for acute depression
Feb 23, 2022
Combinations using an antagonist of presynaptic α2-autoreceptors may be an option for depression that does not respond to monotherapy.
Dietary patterns may affect risk for sudden cardiac death
Jun 30, 2021
A higher Mediterranean diet score may reduce the risk for sudden cardiac death, whereas greater adherence to a Southern dietary pattern may increase the risk for sudden cardiac death, but these associations...
One in seven drug supply chain issue reports tied to drug shortages
Apr 10, 2024
Supply disruptions increased for drugs with and without reports at the start of the COVID-19 pandemic.
Yoga may cut migraine frequency
Apr 04, 2022
However, no significant benefit was seen for migraine pain intensity.
Updated booster shots, not original COVID-19 vaccines, should be standard: FDA panel
Jan 27, 2023
Committee members also weighed a proposal to streamline the dosing schedule for COVID-19 vaccines by turning them into annual shots.
Hearing loss linked to increased risk for dementia
Jan 05, 2024
A higher risk for dementia was seen for those with hearing loss not using hearing aids compared with those who were using hearing aids.